|
1
|
Iorio N, Sawaya RA and Friedenberg FK:
Review article: The biology, diagnosis and management of
gastrointestinal stromal tumours. Aliment Pharmacol Ther.
39:1376–1386. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen HL, Xia JG and Ding HB: Imaging
features and differential diagnosis of gastrointestinal stromal
tumor. Yixue Lilun Yu Shijian. 17:2337–2339. 2013.(In Chinese).
|
|
3
|
Bello DM, Dematteo RP and Ariyan CE: The
GIST of targeted therapy for malignant melanoma. Ann Surg Oncol.
21:2059–2067. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Voltaggio L, Murray R, Lasota J and
Miettinen M: Gastric schwannoma: A clinicopathologic study of 51
cases and critical review of the literature. Hum Pathol.
43:650–659. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Corless CL, Barnett CM and Heinrich MC:
Gastrointestinal stromal tumours: Origin and molecular oncology.
Nat Rev Cancer. 11:865–878. 2011.PubMed/NCBI
|
|
6
|
Miettinen M and Lasota J: Histopathology
of gastrointestinal stromal tumor. J Surg Oncol. 104:865–873. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fan CHL and Li ZHQ: Clinical pathological
and immunohistochemical characteristics of 78 cases of
gastrointestinal stromal tumor. Shi Yong Zhong Liu Za Zhi.
25:581–583. 2010.(In Chinese).
|
|
8
|
Liu SW, Chen GH and Hsieh PP: Collision
tumor of the stomach: A case report of mixed gastrointestinal
stromal tumor and adeno-carcinoma. J Clin Gastroenterol.
35:332–334. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Herbers AH and Keuning JJ: Staging for
CLL-type non-Hodgkin lymphoma reveals a gastrointestinal stromal
tumour. Neth J Med. 63:74–75. 2005.PubMed/NCBI
|
|
10
|
Agaimy A, Wünsch PH, Sobin LH, Lasota J
and Miettinen M: Occurrence of other malignancies in patients with
gastro-intestinal stromal tumors. Semin Diagn Pathol. 23:120–129.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Joo YB, Choi SH, Kim SK, Shim B, Kim MS
and Kim YJ: Synchronous development of KIT positive acute myeloid
leukemia in a patient with gastrointestinal stromal tumor. Korean J
Hematol. 45:66–69. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hematology Society, Chinese Medical
Association: Adult acute myeloid leukemia (non acute early myeloid
leukemia) Chinese guidelines for diagnosis and treatment. (2011
Edition). Chinese Journal of Hematology. 32:1–4. 2011.(In Chinese).
PubMed/NCBI
|
|
13
|
Sonmez M, Arslan M, Cobanoglu U, Kavgaci
H, Ozbas HM, Aydin F, Ovali E and Omay SB: Association of
gastrointestinal stromal tumor and acute myeloid leukemia preceded
by myelodysplastic syndrome with refractory anemia. Tumori.
95:240–242. 2009.PubMed/NCBI
|
|
14
|
Kim MN, Kang SJ, Kim SG, Im JP, Kim JS,
Jung HC and Song IS: Prediction of risk of malignancy of
gastrointestinal stromal tumors by endoscopic ultrasonography. Gut
Liver. 7:642–647. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lewin KJ, Riddell RH and Weinstein WM:
Gastrointestinal Pathology and Its Clinical Implications.
Igaku-Shoin. New York, NY: 284–341. 1992.
|
|
16
|
Corless CL, Fletcher JA and Heinrich MC:
Biology of gastrointestinal stromal tumors. J Clin Oncol.
22:3813–3825. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Joensuu H: Gastrointestinal stromal tumor
(GIST). Ann Oncol. 7(Suppl 10×): 280–x286. 2006. View Article : Google Scholar
|
|
18
|
Yoshioka K, Yamaguchi M, Kasamatsu Y,
Ashida K, Yokoh S, Tatebe A, Yoshida T and Kondo M: Acute
promyoelocytic leukemia following leiomyosarcoma of the jejunum.
Arch Intern Med. 157:1392–1393. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Antonescu CR: The GIST paradigm: Lessons
for other kinase-driven cancers. J Pathol. 223:251–261. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamanoi K, Higuchi K, Kishimoto H, Nishida
Y, Nakamura M, Sudoh M and Hirota S: Multiple gastrointestinal
stromal tumors with novel germline c-kit gene mutation, K642T, at
exon 13. Hum Pathol. 45:884–888. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Conca E, Miranda C, Dal Col V, Fumagalli
E, Pelosi G, Mazzoni M, Fermeglia M, Laurini E, Pierotti MA,
Pilotti S, et al: Are two better than one? A novel double-mutant
KIT in GIST that responds to Imatinib. Mol Oncol. 7:756–762. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shen HQ, Tang YM, Yang SL, Qian BQ, Song
H, Shi SW and Xu WQ: Analysis of CD117 expression on leukemia
cells. Zhonghua Xue Ye Xue Za Zhi. 24:228–230. 2003.(In Chinese).
PubMed/NCBI
|
|
23
|
Tsao AS, Kantarjian H, Thomas D, Giles F,
Cortes J, Garcia-Manero G, Huh Y, Yang Y, Shen Y, Albitar M, et al:
C-kit receptor expression in acute leukemias-association with
patient and disease characteristics and with outcome. Leuk Res.
28:373–378. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang WL, Conley A, Reynoso D, Nolden L,
Lazar AJ, George S and Trent JC: Mechanisms of resistance to
imatinib and sunitinib in gastrointestinal stromal tumor. Cancer
Chemother Pharmacol. 67(Suppl 1): S15–S24. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen SQ and Xiong AQ: The progress and
implication of stem cell factor. Basic Med Sci Clin. 22:385–390.
2002.
|
|
26
|
Miettinen M, Kraszewska E, Sobin LH and
Lasota J: A nonrandom association between gastrointestinal stromal
tumors and myeloid leukemia. Cancer. 112:645–649. 2008. View Article : Google Scholar : PubMed/NCBI
|
